NRAS and acute myeloid leukemia: Recipient mice transplanted with AE9+Nras‐transduced p53EE/EE or p53−/− HSCs succumbed to AML with indistinguishably short latency and significantly earlier than mice transplanted with AE9+Nras‐transduced p53+/+ HSCs (Fig 6E).